Clinical trial
A Dose Finding Study of Fluvastatin for in Vivo Demonstration of Inhibiting Hepatitis C Replication in Patients Infected With Chronic Hepatitis C With Special Attention to the African-American Population.
NCT00441493 is registered in ClinicalTrials.gov with Bader, Ted, M.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Dose Finding Study of Fluvastatin for in Vivo Demonstration of Inhibiting Hepatitis C Replication in Patients Infected With Chronic Hepatitis C With Special Attention to the African-American Population.
- Lead sponsor
- Bader, Ted, M.D.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- September 30, 2007
- Enrollment
- 32
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.